Strategies for the preclinical and clinical characterization of immunogenicityKOREN, E; MYTYCH, D; KOSCEC, M et al.Developments in biologicals. 2005, Vol 122, pp 195-200, issn 1424-6074, 6 p.Conference Paper

Interchangeability, immunogenicity and biosimilarsEBBERS, Hans C; CROW, Stacy A; VULTO, Arnold G et al.Nature biotechnology (Print). 2012, Vol 30, Num 12, pp 1186-1190, issn 1087-0156, 5 p.Article

A randomized study of a flexible booster dosing regimen of VAQTA® in adults: safety, tolerability, and immunogenicityHORNICK, Richard; TUCKER, Richard; KAPLAN, Karen M et al.Vaccine. 2001, Vol 19, Num 32, pp 4727-4731, issn 0264-410XArticle

Enhanced immunogenicity of a contraceptive vaccine using diverse synthetic carriers with permissible adjuvantGUPTA, Anushree; PAL, Rahul; AHLAWAT, Sarita et al.Vaccine. 2001, Vol 19, Num 25-26, pp 3384-3389, issn 0264-410XArticle

A parallel approach to the discovery of carrier delivery vehicles to enhance antigen immunogenicityDELGADO, Mercedes; KYUNG JOO LEE; ALTOBELL, Lawrence III et al.Journal of the American Chemical Society. 2002, Vol 124, Num 18, pp 4946-4947, issn 0002-7863Article

Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvantsLOWELL, G. H; SMITH, L. F; SEID, R. C et al.The Journal of experimental medicine. 1988, Vol 167, Num 2, pp 658-663, issn 0022-1007Article

Immunogenicity assessment in non-clinical studiesSWANSON, Steven J; BUSSIERE, Jeanine.Current opinion in microbiology. 2012, Vol 15, Num 3, pp 337-347, issn 1369-5274, 11 p.Article

Biosimilars in rheumatology: pharmacological and pharmacoeconomic issuesLAPADULA, G; FERRACCIOLI, G. F.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 4, issn 0392-856X, S102-S106, SUP73Article

Immunogenicity of xenopeptide hormone therapiesSCHNABEL, Catherine A; FINEBERG, S. Edwin; KIM, Dennis D et al.Peptides (New York, NY. 1980). 2006, Vol 27, Num 7, pp 1902-1910, issn 0196-9781, 9 p.Article

Immunogenicity of constitutively active ^vs99eBRafANDERSEN, Mads Hald; FENSTERLE, Joachim; STRATEN, Per Thor et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5456-5460, issn 0008-5472, 5 p.Article

Covalent complexes of antigen and α₂-macroglobulin : evidence for dramatically-increased immunogenicityCIANCIOLO, George J; ENGHILD, Jan J; PIZZO, Salvatore V et al.Vaccine. 2001, Vol 20, Num 3-4, pp 554-562, issn 0264-410XArticle

Relationships among physico-chemical and biological tests for a synthetic Hib-TT conjugate vaccineLANDYS CHOVEL CUERVO, Mario; PEREZ, Lidia Rosa; OVIEDO, Maite et al.Vaccine. 2007, Vol 25, Num 1, pp 194-200, issn 0264-410X, 7 p.Article

Glycan-Dependent Immunogenicity of Recombinant Soluble Trimeric HemagglutininDE VRIES, Robert P; SMIT, Cornelis H; HOKKE, Cornelis H et al.Journal of virology. 2012, Vol 86, Num 21, pp 11735-11744, issn 0022-538X, 10 p.Article

Apport de la philosophie à la question de l'immunogénicité = What philosophy can say about immunogenicityPRADEU, Thomas.La Presse médicale (1983). 2010, Vol 39, Num 7-8, pp 747-752, issn 0755-4982, 6 p.Article

Principles of vaccine design: Lessons from natureZEPP, Fred.Vaccine. Supplement. 2010, Vol 28, Num 3, issn 1359-5938, C14-C24Article

Comparative antigenicity and immunogenicity of hepadnavirus core proteinsBILLAUD, Jean-Noel; PETERSON, Darrell; MILICH, David et al.Journal of virology. 2005, Vol 79, Num 21, pp 13641-13655, issn 0022-538X, 15 p.Article

On the applicability in biology of the theory of self-organization of the systemsFIRRAO, S.Cybernetica. 1992, Vol 35, Num 1, pp 5-15, issn 0011-4227Article

Changes in the immunogenicity in a number of bacterial antigens under the influence of a muramyl dipeptide derivativeBRITSINA, M. V; SHEPELEVA, I. B; BATURO, A. P et al.Žurnal mikrobiologii, èpidemiologii i immunobiologii. 1992, Num 5-6, pp 43-45, issn 0372-9311Article

Production and characterization of antibodies against nivalenol tetraacetateCHENG-RUI WANG; CHU, F. S.Applied and environmental microbiology (Print). 1991, Vol 57, Num 4, pp 1026-1030, issn 0099-2240Article

Differential Effects of Viral Vectors on Migratory Afferent Lymph Dendritic Cells In Vitro Predict Enhanced Immunogenicity In VivoCUBILLOS-ZAPATA, C; GUZMAN, E; TURNER, A et al.Journal of virology. 2011, Vol 85, Num 18, pp 9385-9394, issn 0022-538X, 10 p.Article

Enbrel® (Etanercept)FOERDER, C. A; ROGGE, M. C.Developments in biologicals. 2002, Vol 109, pp 99-102, issn 1424-6074, 4 p.Conference Paper

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectorsJACKSON, Lisa A; AUSTIN, Glenn; CHEN, Robert T et al.Vaccine. 2001, Vol 19, Num 32, pp 4703-4709, issn 0264-410XArticle

The immunogenicity of tumour cellsASHMAN, L. K.Immunology and cell biology. 1987, Vol 65, Num 4, pp 271-277, issn 0818-9641Article

Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZV_HT) in Immunocompromised AdultsMULLANE, Kathleen M; WINSTON, Drew J; YANLI ZHAO et al.The Journal of infectious diseases. 2013, Vol 208, Num 9, pp 1375-1385, issn 0022-1899, 11 p.Article

Biosimilars and biobetters as tools for understanding and mitigating the immunogenicity of biotherapeuticsBARBOSA, Maria D. F. S; KUMAR, Sandeep; LOUGHREY, Helen et al.Drug discovery today. 2012, Vol 17, Num 23-24, pp 1282-1288, issn 1359-6446, 7 p.Article